1. Annual Report 2025
  2. Research
  3. GR-SISAP

GR-SISAP

Research group on information systems for AP services

The SISAP research group (GR-SISAP) is a multidisciplinary team that includes specialists in preventive medicine, family medicine and statistics.

The group aims to develop research in the field of primary care information systems. This includes studies on the use of indicators or clinical practice support tools created from data in the computerised medical record; but also undertaking work in the field of the organisation and management of primary care teams (PCTs), and epidemiological and public health analyses from the perspective of primary care (PC). Thus, the group is committed to rigorous research and the practical applicability of its findings in the day-to-day work of primary care professionals, in order to improve clinical practice and population health.

Over the last four years, the group's members have carried out various research projects, both independently and in collaboration with other established groups at the IDIAP. (GAVINA, PROSAARU, RWEpi), with the BIOCOM-SC research group (Computational Biology Group) of the Polytechnic University of Catalonia, the COPEDI-CAT paediatric health research group, the University of Oxford and the General Secretariat of Public Health.

Group projects

  • Estudi d'activitats formatives Gamificades respecte a Activitats Teòriques en HIpertensió Arterial per a medicina i infermeria. Estudi GATHiTA-1. ICS - Institut Català de la Salut. 2025-2028. IP: Mència Benítez Camps.

  • Cribratge, detecció i abordatge de la malaltia renal crònica a l'atenció primària: comparació de resultats 2016-2021. ICS - Institut Català de la Salut. 2022-2025. IP: Mència Benítez Camps.

Group publications

  • Suñer C, Escrig Sarreta R, Galván Casas C, Matos E, Gabster A, Wolff M et al. Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk Populations. Vaccines. 2025;13(6):PMID:40573925.

  • Zaldua YC, Martin SM, Bret JS, Perez EH, Redon EC, Noguerola SR. Simulated Clinical Stations in Quality and Patient Safety in a Primary Care Setting. Healthcare. 2025;13(13):PMID:40648526.

  • Perramon Malavez A, Buonsenso D, Morello R, Coma E, Foster S, Leonard P et al. Real-world impact of nirsevimab immunisation against respiratory disease on emergency department attendances and admissions among infants: a multinational retrospective analysis. Lancet Reg. Health-Eur. 2025;55101334-101334. PMID:40950943.

  • Marzo Castillejo M, Mascort Roca J, Brau Tarrida A, Carrasco Ribelles L, Monteagudo Zaragoza M, Guiriguet Capdevila C et al. Participant selection for lung cancer screening using primary care electronic medical records: The Catalan scenario. Aten. Prim. 2026;58(1):103363-103363. PMID:41260054.

  • Coma E, Martinez Marcos M, Hermosilla E, Mendioroz J, Reñe A, Fina F et al. Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes in hospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infants in their second year of life in Catalonia, Spain. Eur. J. Pediatr. 2025;184(10):616-616. PMID:40946115.

  • Esteban Fabró R, Coma E, Marin Gomez FX, Hermosilla E, Mendez Boo L, Guiriguet C et al. Financial incentives and information provision for post-pandemic primary care quality recovery: a longitudinal study in Catalonia. Br. J. Gen. Pract. 2026; PMID:41344817.

  • González Sánchez A, Andrés C, Prats Méndez I, Piñana M, Coma E, Bernet A et al. Evolutionary dynamics of HRSV following the implementation of nirsevimab immunoprophylaxis in Catalonia (2023-2024). J. Infect. 2025;91(3):106567-106567. PMID:40769426.

  • Coma E, Martinez Marcos M, Hermosilla E, Mendioroz J, Rene A, Avilés FF et al. Effectiveness of nirsevimab against RSV-related outcomes: findings of the 2024-2025 campaign in Catalonia align with previous analysis. Arch. Dis. Child. 2025;110(12):1024-1025. PMID:40499942.

  • Gibrat Pineda M, Torras Borrell J, Benítez Camps M, Cecilia Salgueiro M, Rebagliato Nadal O, González Gil L et al. Pilot Study for the Evaluation of the Learning with a Card's Gamified Aactivity in Hypertension. J. Hypertens. 2025;43(SUPPL 1):

  • Vanrell Nicolau M, Benitez Camps M, Torras Borrell J, Rebagliato Nadal O, Priego Artero M, Cecilia Salgueiro M et al. Pilot Study for the Evaluation of the Learning of a Gamified Activity for Competitive Teams of Questions-and-Answers in Arterial Hypertension. J. Hypertens. 2025;43(SUPPL 1):204-205.

  • Salgueiro MC, Benítez Camps M, Torras Borrell J, Gibrat Pineda M, Rebagliato Nadal O, Vanrell Nicolau M et al. Evaluation of Satisfaction Level with a Card Game for Learning Hypertension Management. J. Hypertens. 2025;43(SUPPL 1):

  • Priego Artero M, Cecilia Salgueiro M, Torras Borrell J, Rebagliato Nadal O, Benítez Camps M, Rosinach Bonet J et al. Comparison About Special Situations Between 2021 National Hypertension Guidelines and 2023 European Society of Hypertension Guidelines. J. Hypertens. 2025;43(SUPPL 1):203-204.

  • Benitez Camps M, Torras Borrell J, Vanrell Nicolau M, Rebagliato Nadal O, Priego Artero M, Cecilia Salgueiro M et al. A NEW Questions-and-Answers Game in Hypertension for Continuing Education Among Health Professionals. J. Hypertens. 2025;43(SUPPL 1):

  • Torras Borrell J, Benítez Camps M, Gibrat Pineda M, Cecilia Salgueiro M, Vanrell Nicolau M, Rebagliato Nadal O et al. A New Card Game in Hypertension for Continuing Education Among Health Professionals. J. Hypertens. 2025;43(SUPPL 1).

Anar a l'inici